Stress and the prodromal phase of psychosis

Current Pharmaceutical Design

Volumn 18, Issue 4, 2012, Pages 527-533

  Holtzman, Carrie W ^a   Shapiro, Daniel I ^a   Trotman, Hanan D ^a   Walker, Elaine F ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Hypothalamic pituitary adrenal HPA axis; Prodrome; Psychosis; Schizophrenia; Stress; Trauma; Ultra high risk

Indexed keywords

ADRENALIN; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; NORADRENALIN;

ADOLESCENT DEVELOPMENT; CHILDHOOD INJURY; DISEASE SEVERITY; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MENTAL STRESS; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA;

EARLY DIAGNOSIS; HUMANS; PSYCHOTIC DISORDERS; SCHIZOPHRENIC PSYCHOLOGY; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 84856555751     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212799316280     Document Type: Review

References (99)

1. Yung AR, McGorry, PD. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust N Z J Psychiatry 1996; 30: 587-99.
2. McGlashan TH, Miller TJ, Woods SW, Rosen JL, Hoffman RE, Davidson L. Structured interview for prodromal syndromes, Ver. 4.0. New Haven, CT: Yale School of Medicine; 2003.
3. Yung A, Phillips L, McGorry P, Ward J, Donovan K, Thompson K. Comprehensive assessment of at risk mental states (CAARMS), Melbourne: University of Melbourne; 2002.
4. Addington J, Cadenhead KS, Cannon TD, et al. North American Prodrome Longitudinal Study: A collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull 2007; 33(3): 665-72.
5. Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E. The schizophrenia prodrome revisited: A neurodevelopmental perspective. Schizophr Bull 2003; 29(4): 633-51.
6. Cannon TD, Cadenhead K, Cornblatt B, et al. Prediction of psychosis in youth at high clinical risk. Arch Gen Psychiatry 2008; 65(1): 28-37.
7. Ruhrmann S, Schultze-Lutter F, Salokangas RKR, et al. Prediction of psychosis in adolescents and young adults at high risk: Results from the Prospective European Prediction of Psychosis study. Arch Gen Psychiatry 2010; 67(3): 241-51.
8. Thompson A, Nelson B, Yung A. Predictive validity of clinical variables in the "at risk" for psychosis population: International comparison with results from the North American Prodrome Longitudinal Study. Schizophr Res 2011; 127: 107-14.
9. Rosenthal D. A suggested conceptual framework. In: Rosenthal D, Ed. The Genain quadruplets. New York: Basic Books; 1963. pp. 505-16.
10. Corcoran C, Walker EF, Huot R, et al. The stress cascade and schizophrenia: Etiology and onset. Schizophr Bull 2003; 29(4): 671-92.
11. Phillips LJ, Francey SM, Edwards J, McMurray N. Stress and psychosis: Towards the development of new models of investigation. Clin Psychol Rev 2007; 27: 307-17.
12. Walker E, Mittal V, Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psycho 2008; 4: 189-216.
13. Morgan C, Fisher H. Environmental factors in schizophrenia: Childhood trauma-a critical review. Schizophr Bull 2007; 33(1): 3-10.
14. Bendall S, Jackson HJ, Hulbert CA, McGorry, PD. Childhood trauma and psychotic disorders: A systematic, critical review of the evidence. Schizophr Bull 2008; 34(3): 568-79.
15. Read J, van Os J, Morrison AP, Ross CA. Childhood trauma, psychosis, and schizophrenia: A literature review with theoretical and clinical implications. Acta Psychiat Scand 2005; 112: 330-50.
16. Horan WP, Ventura J, Nuechterlein KH, Subotnik KL, Hwang SS, Mintz J. Stressful life events in recent-onset schizophrenia: Reduced frequencies and altered subjective appraisals. Schizophr Res 2005; 75: 363-74.
17. Walker EF, Diforio D. Schizophrenia: A neural-diathesis stress model. Psychol Rev 1997; 104(4): 667-85.
18. Myin-Germeys I, van Os J, Schwartz JE, Stone AA, Delespaul PA. Emotional reactivity to daily life stress in psychosis. Arch Gen Psychiatry 2001; 58: 1137-44.
19. Myin-Germeys I, Delespaul P, van Os J. Behavioural sensitization to daily life stress in psychosis. Psychol Med 2005; 35: 733-41.
20. Hempel RJ, Tulen JH, van Beveren NJ, van Steenis HG, Mulder PG, Hengeveld MW. Physiological responsivity to emotional pictures in schizophrenia. J Psychiat Res 2005; 39(5): 509-18.
21. Lim CL, Gordon E, Harris A, Bahramali H, Li WM, Manor B, Rennie C. Electrodermal activity in schizophrenia: a quantitative study using a short interstimulus paradigm. Biol Psychiat 1999; 45(1): 127-35.
22. Dawson ME, Schell AM, Rissling A, Ventura J, Subotnik KL, Nuechterlein KH. Psychophysiological prodromal signs of schizophrenic relapse: A pilot study. Schizophr Res 2010; 123: 64-7.
23. Spauwen J, Krabbendam L, Lieb R, Wittchen HU, van Os J. Impact of psychological trauma on the development of psychotic symptoms: Relationship with psychosis proneness. Br J Psychiatry 2006; 188: 527-33.
24. Janssen I, Krabbendam L, Bak M, Hanssen M, Vollebergh W, de Graaf R, van Os J. Childhood abuse as a risk factor for psychotic experiences. Acta Psychatrica Scandinavica 2004; 109: 38-45.
25. Gaudiano BA, Zimmerman M. The relationship between childhood trauma history and the psychotic subtype of major depression. Acta Psychiat Scand 2010; 121: 462-70.
26. Burns JK, Jhazbhay K, Esterhuizen T, Emsley R. Exposure to trauma and the clinical presentation of first-episode psychosis in South Africa. J Psychiatr Res 2011; 45: 179-84.
27. Schenkel LS, Spaulding WD, DiLillo D, Silverstein SM. Histories of childhood maltreatment in schizophrenia: Relationships with premorbid functioning, symptomatology, and cognitive deficits. Schizophr Res 2005; 76: 273-86.
28. Lysaker PH, Beattie NL, Strasburger AM, Davis LW. Reported history of child sexual abuse in schizophrenia: Associations with heightened symptom levels and poorer participation over four months in vocational rehabilitation. J Nerv Ment Dis 2005; 193(12): 790-5.
29. Alvarez M-J, Osés A, Foguet Q, Solà J, & Arrufat F-X. Prevalence and clinical impact of childhood trauma in patients with severe mental disorders. J Nerv Ment Dis 2011; 199(3): 156-61.
30. Lardinois M, Lataster T, Mengelers R, van Os J, Myin-Germeys I. Childhood trauma and increased stress sensitivity in psychosis. Acta Psychiat Scand 2011; 123: 28-35.
31. Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: assessment instruments. Acta Psychiat Scand 2006; 113(4): 273-82.
32. Gross G, Huber G, Klosterkötter J. Bonn scale for the assessment of basic symptoms - BSABS. Berlin: Springer; 1987.
33. Schultze-Lutter F, Wieneke A, Picker H, Rolff Y, Steinmeyer EM, Ruhrmann S, Klosterkotter J. The schizophrenia prediction instrument, adult version (SPI-A). Schizophr Res 2004; 70(suppl.): 76-7.
34. Correll CU, Hauser M, Auther AM, Cornblatt BA. Research in people with psychosis risk syndrome: a review of the current evidence and future directions. J Child Psychol Psyc 2010; 51(4): 390-431.
35. Simon AE, Umbricht D. High remission rates from an initial ultrahigh risk state for psychosis. Schizophr Res 2010; 116(2-3): 168-72.
36. Walker E., Shapiro D., Esterberg M, Trotman, H. Neurodevelopment and Schizophrenia: Broadening the focus. Curr Dir Psychol Sci 2010; 19(4): 204-8.
37. Gunnar MR, Wewerka S, Frenn K, Long JD, Griggs C. Developmental changes in hypothalamus-pituitary-adrenal activity over the transition to adolescence: Normative changes and associations with puberty. Dev Psychopathol 2009; 21: 69-85.
38. McCormick CM, Mathews IZ, Thomas C, Waters P. Investigations of HPA function and the enduring consequences of stressors in adolescence in animal models. Brain Cognition 2010; 72(1): 73-85.
39. Spear LP. Heightened stress responsivity and emotional reactivity during pubertal maturation: Implications for psychopathology. Dev Psychopathol 2009; 21(1): 87-97.
40. Pruessner M, Iyer SN, Faridi K, Joober R, Malla AK. Stress and protective factors in individuals at ultra-high risk for psychosis, first episode psychosis, and healthy controls. Schizophr Res 2011, June; 129(1): 29-35.
41. Thompson JL, Kelly M, Kimhy D, et al. Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis. Schizophr Res 2009; 108: 176-81.
42. Bechdolf A, Thompson A, Nelson B, et al. Experience of trauma and conversion to psychosis in an ultra-high-risk (prodromal) group. Acta Psychiat Scand 2010; 121: 377-84.
43. Jameison K, Dinan TG. Glucocorticoids and cognitive function: from physiology to pathophysiology. Hum Psychopharmacol 2001; 16: 293-302.
44. Lupien SJ, Maheu F, Tu M, Fiocco A, Schramek TE. The effects of stress and stress hormones on human cognition: Implications for the field of brain and cognition. Brain Cognition 2007; 65: 209-37.
45. Kiess K, Meidert A, Dressendörfer RA, et al. Salivary cortisol levels throughout childhood and adolescence: Relation with age, pubertal stage and weight. Pediatr Res 1995; 37: 502-6.
46. Kirschbaum C, Hellhammer D. Salivary cortisol in psychobiological research: an overview. Neuropsychobiology 1989; 22(3): 150-69.
47. Levine A, Zagoory-Sharon O, Feldman R, Lewis JG, Weller A. Measuring cortisol in human psychobiological studies. Physiol Behav 2007; 90(1): 43-53.
48. Oitzl MS, Champagne DL, van der Veen R, de Kloet ER. Brain development under stress: hypotheses of glucocorticoid actions revisited. Neurosci Biohehav R 2010; 34(6): 853-66.
49. Taliaz D, Loya A, Gersner R, Haramati S, Chen A, Zangen A. Resilience to chronic stress is mediated by hippocampal brainderived neurotrophic factor. J Neurosci 2011; 31(12): 4475-83.
50. Mannie ZN, Harmer CJ, Cowen PJ. Increased waking salivary cortisol levels in young people at familial risk of depression. Am J Psychiatry 2007; 164: 617-21.
51. Hinkelman K, Moritz S, Botzenhardt J, et al. Cognitive impairment in major depression: association with salivary cortisol. Biol Psychiatry 2009; 66: 879-85.
52. Garner B, Phassouliotis C, Phillips LJ, et al. Cortisol and dehydroepiandrosterone-sulphate levels correlate with symptom severity in first-episode psychosis. J Psychiatr Res 2011; 45(2): 249-55.
53. Phillips LJ, McGorry PD, Garner B, Thompson KN, Pantelis C, Wood SJ, Berger G. Stress, the hippocampus, and the hypothalamic-pituitary-adrenal axis: Implications for the development of psychotic disorders. Aust N Z J Psychiatry 2006; 40: 725-41.
54. Ryan MC, Sharifi N, Condren R, Thakore, JH. Evidence of basal pituitary-adrenal overactivity in first episode, drug-naïve patients with schizophrenia. Psychoneuroendocrinology 2004; 29(8): 1065-70.
55. Sharma RP, Pandey GN, Janicak PG, Peterson J, Comaty JE, Davis JM. The effect of diagnosis and age on the DST: A metaanalytic approach. Biol Psychiatry 1988; 24: 555-68.
56. Yeragani VK. The incidence of abnormal dexamethasone suppression in schizophrenia: A review and a meta-analytic comparison with the incidence in normal controls. Can J Psychiatry 1990; 35: 128-32.
57. Nelson JC, Davis JM. DST studies in psychotic depression: A meta-analysis. Am J Psychiatry 1997; 154: 1497-503.
58. Duval F, Mokrani MC, Crocq MA, et al. Dopaminergic function and the cortisol response to dexamethasone in psychotic depression. Progress in Neuropsychopharmacol Biol Psychiatry 2000; 24: 207-25.
59. Heckers S, Konradi C. Hippocampal pathology in schizophrenia. Curr Top Beh Neurosci 2010; 4: 529-53.
60. Tessner KD, Walker EF, Dhruv SH, Hochman K, Hamann S. The relation of cortisol levels with hippocampus volumes under baseline and challenge conditions. Brain Res 2007; 1179: 70-8.
61. Papagni, SA, Benetti, S, Arulanantham, S, McCrory, E, McGuire, P, Mechelli, A. Effects of stressful life events on human brain structure: A longitudinal voxel-based morphometry study. Stress 2011; 14(2): 227-32.
62. Bennett MR. Stress and anxiety in schizophrenia and depression: Glucocorticoids, corticotrophin-releasing hormone, and synapse regression. Aust NZ J Psychiat 2008; 42: 995-1002.
63. Belanoff JK, Gross K, Yager A, Schatzberg AF. Corticosteroids and cognition. J Psychiatr Res 2001; 35: 127-45.
64. Sapolsky R. Stress and plasticity in the limbic system. Neurochem Res 2003; 28(11): 1735-42.
65. Schoenfeld TJ., Gould E. Stress, stress hormones, and adult neurogenesis. Exp Neurol. Forthcoming 2011.
66. Yu S, Holsboer F, Almeida OFX. Neuronal actions of glucocorticoids: Focus on depression. J Steroid Biochem 2008; 108: 300-9.
67. Mann K, Rossbach W, Muller, MJ, et al. Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine. Psychoneuroendocrinology 2006; 31(2): 256-64.
68. Safont G, Corripio I, Escartí MJ, et al. Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: An in vivo SPECT study. Schizophr Res. Forthcoming 2011 April 1.
69. Abi-Dargham A. Do we still believe in the dopamine hypothesis? New data bring new evidence. International Journal of Neuropsychopharmacology 2004; 7(Suppl. 1): S1-S5.
70. Kamiyama H, Matsumoto M, Otani S, et al. Mechanisms underlying ketamine-induced synaptic depression in rat hippocampusmedial prefrontal cortex pathway. Neurosci 2011; 177: 159-69.
71. Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: Version III-the final common pathway. Schizophr Bull 2009; 35(3): 549-62.
72. van Winkel R, Stefanis NC, Myin-Germeys I. Psychosocial stress and psychosis: A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull 2008; 34(6): 1095-105.
73. Pruessner JC, Champagne F, Meaney MJ, Dagher A. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. J Neurosci 2004; 24(11): 2825-31.
74. Brunelin J, d'Amato T, van Os J, Costes N, Chagny M-FS, Saoud M. Increased left striatal dopamine transmission in unaffected siblings of schizophrenia patients in response to acute metabolic stress. Psychiat Res-Neuroim 2010; 181: 130-5.
75. Pariante CM. Pituitary volume in psychosis: The first review of the evidence. J Psychopharmacol, 2008; 22(Suppl. 2): 76-81.
76. Takahashi T, Suzuki M, Velakoulis D, et al. Increased pituitary volume in schizophrenia spectrum disorders. Schizophr Res 2009; 108: 114-21.
77. Büschlen J, Berger GE, Borgwardt SJ, et al. Pituitary volume increase during emerging psychosis. Schizophr Res 2011; 125: 41-8.
78. Tournikioti K, Tansella M, Perlini C, et al. Normal pituitary volumes in chronic schizophrenia. Psychiat Res 2007; 154(1): 561-9.
79. Thompson KN, Berger G, Phillips LJ, Komesaroff P, Purcell R, McGorry PD. HPA axis functioning associated with transition to psychosis: Combined DEX/CRH test. J Psychiatr Res 2007; 41: 446-50.
80. Thompson KN, Phillips, LJ, Komesaroff P, et al. Stress and HPAaxis functioning in young people at ultra high risk for psychosis. J Psychiatr Res 2007; 41: 561-9.
81. Walker EF, Brennan PA, Esterberg M, Brasfield J, Pearce B, Compton MT. Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth. J Abnorm Psychol 2010; 119(2): 401-8.
82. Shapiro DI, Pearce B, Trotman HD, et al. Baseline level cortisol secretion in individuals at-risk for developing psychosis. Poster session presented at the annual meeting of the Society for Research in Psychopathology, Seattle, WA. 2010
83. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ. Neuroanatomical abnormalities before and after onset of psychosis: A cross-sectional and longitudinal MRI comparison. Lancet 2003; 361: 281-8.
84. Velakoulis D, Wood SJ, Wong MTH, McGorry PD, Yung A, Phillips L. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: A magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiat 2006; 63: 139-49.
85. Wood SJ, Kennedy D, Phillips LJ, Seal ML, Yücel M, Nelson B. Hippocampal pathology in individuals at ultra-high risk for psychosis: A multi-modal magnetic resonance study. Neuroimage 2010; 52: 62-8.
86. Witthaus H, Mendes U, Brüne M, et al. Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia. J Psychiatr Neurosci 2010; 35(1): 33-40.
87. Hurlemann R, Jessen F, Wagner M, et al. Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state. Psychol Med 2008; 38(6): 843-51.
88. Schobel SA, Lewandowski NM, Corcoran CM, Moore H, Brown T, Malaspina D, Small SA. Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Arch Gen Psychiat 2009; 66(9): 938-46.
89. Borgwardt S, Smieskova R, Bendfeldt K, et al. Hippocampal volume reduction specific for later transition to psychosis or substance-associated effects? J Psychiatr Neurosci 2010; 35(3): 214-5.
90. Garner B, Pariante CM, Wood SJ, et al. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol Psychiat 2005; 58: 417-23.
91. Braehler C, Holowka D, Brunet A, et al. Diurnal cortisol in schizophrenia patients with childhood trauma. Schizophr Res 2005; 79: 353-54.
92. Yehuda R. Biology of posttraumatic stress disorder. J Clin Psychiat 2001; 62(Suppl. 17): 41-6.
93. Faravelli C, Gorini Amadei S, Rotella F, et al. Childhood traumata, dexamethasone suppression test, and psychiatric symptoms: A trans-diagnostic approach. Psychol Med 2010; 40: 2037-48.
94. Gunnar M, Quevedo K. The neurobiology of stress and development. Annu Rev Psychol 2007; 58: 145-73.
95. Gutman DA, Nemeroff CB. Persistent central nervous system effects of an adverse early environment: Clinical and preclinical studies. Physiol Behav 2003; 79: 471-8.
96. McEwen BS. Understanding the potency of stressful early life experiences on brain and body function. Metabolism 2008; 57(Suppl. 2): S11-15.
97. Huot RL, Plotsky PM, Lenox RH, McNamara RK. Neonatal maternal separation reduces hippocampal mossy fiber density in adult Long Evans rats. Brain Res 2002; 950: 52-63.
98. Mirescu C, Peters JD, Gould E. Early life experience alters response of adult neurogenesis to stress. Nat Neurosci 2004; 7(8): 841-6.
99. Coplan JD, Andrews MW, Rosenblum LA, et al. Persistent elevations of cerebrospinal fluid concentrations of corticotropinreleasing factor in adult nonhuman primates exposed to early-life stressors: Implications for the pathophysiology of mood and anxiety disorders. Proc Natl Acad Sci USA 1996; 93: 1619-23.